Sirtex Medical Inc. Half-Year Dose Sales Surge 28 Percent in Advance of SIRFLOX Primary Endpoint Announcement

Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited , has announced that dose sales of SIR-Spheres® Y-90 resin microspheres in the Americas region grew more than 28 percent for the first half of the company’s fiscal year compared to the same period last year, with 3,390 doses supplied for the period July through December 2014.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1AF4JMD

via IFTTT